AiM Medical Robotics Appoints Dr. Gregory Cole as Chief Technology Officer
FORT LAUDERDALE, Fla., Feb. 17, 2022 /PRNewswire/ -- AiM Medical Robotics, a leading developer of MRI-compatible intraoperative robotics for neurosurgery, today announced that Gregory Cole, Ph.D., has been appointed as its first Chief Technology Officer (CTO).
- FORT LAUDERDALE, Fla., Feb. 17, 2022 /PRNewswire/ -- AiM Medical Robotics, a leading developer of MRI-compatible intraoperative robotics for neurosurgery, today announced that Gregory Cole, Ph.D., has been appointed as its first Chief Technology Officer (CTO).
- He will report directly to the Chief Executive Officer (CEO) of AiM, Bob Cathcart, and will build and lead the teams of engineers and researchers that will develop and launch the company's core MRI-compatible robotics platform.
- As a graduate student, Dr. Cole collaborated with Dr. Gregory Fischer on research in interventional robotics and co-founded Medical Motion Corporation to enable the development of robotic surgical technologies by other universities.
- AiM Medical Robotics is a privately held biotechnology company currently focused on the development of MRI-compatible advanced robotics that are precision-focused, portable, and can be used with any diagnostic MRI scanner.